File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1097/JCMA.0000000000001032
- Scopus: eid_2-s2.0-85184286821
- PMID: 38051043
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Limitations of GPT-4 as a geriatrician in geri-oncology case conference: A case series
Title | Limitations of GPT-4 as a geriatrician in geri-oncology case conference: A case series |
---|---|
Authors | |
Keywords | Case conference Geriatrics GPT-4 Oncology |
Issue Date | 1-Feb-2024 |
Publisher | Wolters Kluwer Health |
Citation | Journal of the Chinese Medical Association, 2024, v. 87, n. 2, p. 148-150 How to Cite? |
Abstract | Generative pre-trained transformer 4 (GPT-4) is an artificial intelligence (AI) system with a chat interface. The number of studies testing GPT-4 in clinical applications has been increasing. We hypothesized that GPT-4 would be able to suggest management strategies for medical issues in elderly oncology patients, similar to those provided by geriatricians. We compared the responses of GPT-4 to those of a geriatrician for four oncological patients. After these case conferences, none of the patients required admission for medical consultation. In three out of four scenarios, GPT-4 was able to offer a multidisciplinary approach in the first prompt. In all three scenarios, GPT-4 identified medication-related side effects and suggested appropriate medications in the first prompt. However, GPT-4 was unable to suggest initial dosages of medications to be used in the first prompt and was unable to suggest a more humanistic and non-pharmacological approach to anorexia, even with a follow-up prompt. In conclusion, GPT-4 may be used as a screening tool to provide potential rudimentary directions for management, which can then be reviewed by medical professionals before considering a formal consultation for more tailored and refined opinions from specialists. |
Persistent Identifier | http://hdl.handle.net/10722/346197 |
ISSN | 2023 Impact Factor: 1.9 2023 SCImago Journal Rankings: 0.507 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kuk, Ling Yuk | - |
dc.contributor.author | Kwong, Dora Lai Wan | - |
dc.contributor.author | Chan, Wing Lok Wendy | - |
dc.contributor.author | Shea, Yat Fung | - |
dc.date.accessioned | 2024-09-12T00:30:47Z | - |
dc.date.available | 2024-09-12T00:30:47Z | - |
dc.date.issued | 2024-02-01 | - |
dc.identifier.citation | Journal of the Chinese Medical Association, 2024, v. 87, n. 2, p. 148-150 | - |
dc.identifier.issn | 1726-4901 | - |
dc.identifier.uri | http://hdl.handle.net/10722/346197 | - |
dc.description.abstract | <p>Generative pre-trained transformer 4 (GPT-4) is an artificial intelligence (AI) system with a chat interface. The number of studies testing GPT-4 in clinical applications has been increasing. We hypothesized that GPT-4 would be able to suggest management strategies for medical issues in elderly oncology patients, similar to those provided by geriatricians. We compared the responses of GPT-4 to those of a geriatrician for four oncological patients. After these case conferences, none of the patients required admission for medical consultation. In three out of four scenarios, GPT-4 was able to offer a multidisciplinary approach in the first prompt. In all three scenarios, GPT-4 identified medication-related side effects and suggested appropriate medications in the first prompt. However, GPT-4 was unable to suggest initial dosages of medications to be used in the first prompt and was unable to suggest a more humanistic and non-pharmacological approach to anorexia, even with a follow-up prompt. In conclusion, GPT-4 may be used as a screening tool to provide potential rudimentary directions for management, which can then be reviewed by medical professionals before considering a formal consultation for more tailored and refined opinions from specialists.</p> | - |
dc.language | eng | - |
dc.publisher | Wolters Kluwer Health | - |
dc.relation.ispartof | Journal of the Chinese Medical Association | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | Case conference | - |
dc.subject | Geriatrics | - |
dc.subject | GPT-4 | - |
dc.subject | Oncology | - |
dc.title | Limitations of GPT-4 as a geriatrician in geri-oncology case conference: A case series | - |
dc.type | Article | - |
dc.identifier.doi | 10.1097/JCMA.0000000000001032 | - |
dc.identifier.pmid | 38051043 | - |
dc.identifier.scopus | eid_2-s2.0-85184286821 | - |
dc.identifier.volume | 87 | - |
dc.identifier.issue | 2 | - |
dc.identifier.spage | 148 | - |
dc.identifier.epage | 150 | - |
dc.identifier.issnl | 1726-4901 | - |